GOALS OF WORK: Sleep disorders have been invariably reported in cancer population. However, the prevalence of this problem in advanced cancer patients has never been assessed. The aim of this study was to evaluate the frequency of sleep disturbances in terms of quantity and quality, and possible associated factors. PATIENTS AND METHODS: A consecutive sample of patients admitted to a pain relief and palliative care unit were surveyed. Patients with severe cognitive problems or who were too ill were excluded. Epidemiological and clinical data, including the performance status, habits, relevant symptoms, and drug use were recorded. Patients were asked to answer a small questionnaire regarding their sleep, and duration and characteristics (nocturnal and diurnal hours slept, falling asleep, awaking, getting back to sleep, early awaking, restoring sleep, nightmares, feeling depressed or anxious). The level of information about the illness was also assessed. MAIN RESULTS: Among the causes of admission, pain control was the main indication (about 58%). Of 123 patients surveyed, 30% slept less than 5 h. Women significantly slept more hours than men (p=0.042). Anxiety (p=0.045), falling asleep (p=0.003), awaking (p=0.035), early awaking (p=0.001), getting beck to sleep (p=0.021), and nightmares (p=0.034), were significantly associated with less hours slept. This relationship was highly significant for less restoring sleep, fatigue, and drowsiness ( p<0.0005). No differences were found for age (p=0.294), primary tumor (p=0.225), level of information ( p=0.529), Karnofsky status (p=0.539), depression (p= 0.095), confusion (p=0.074), possible causes of awaking (p= 0.881), use of opioids (p= 0.798), use of hypnotics (p= 0.197), other morbidities ( p=0.460), or use of alcohol or coffee (p= 0.141). Patients admitted for pain control and/or those receiving opioids more frequently had drowsiness (p=0.01) Patients with lower Karnofsky scores had more drowsiness and diurnal hours slept (p=0.01). Anxiety created more difficulties in falling asleep, produced a less restoring sleep, and nightmares. Depression was associated with early awaking, nonrestorative sleep, fatigue, and nightmares. Confusion was associated with fatigue and nightmares. CONCLUSION: Sleep problems appear to be a significant issue for advanced cancer patients. Attention to sleep disturbance needs to be incorporated into the routine practice in palliative care evaluation.
GOALS OF WORK: Sleep disorders have been invariably reported in cancer population. However, the prevalence of this problem in advanced cancerpatients has never been assessed. The aim of this study was to evaluate the frequency of sleep disturbances in terms of quantity and quality, and possible associated factors. PATIENTS AND METHODS: A consecutive sample of patients admitted to a pain relief and palliative care unit were surveyed. Patients with severe cognitive problems or who were too ill were excluded. Epidemiological and clinical data, including the performance status, habits, relevant symptoms, and drug use were recorded. Patients were asked to answer a small questionnaire regarding their sleep, and duration and characteristics (nocturnal and diurnal hours slept, falling asleep, awaking, getting back to sleep, early awaking, restoring sleep, nightmares, feeling depressed or anxious). The level of information about the illness was also assessed. MAIN RESULTS: Among the causes of admission, pain control was the main indication (about 58%). Of 123 patients surveyed, 30% slept less than 5 h. Women significantly slept more hours than men (p=0.042). Anxiety (p=0.045), falling asleep (p=0.003), awaking (p=0.035), early awaking (p=0.001), getting beck to sleep (p=0.021), and nightmares (p=0.034), were significantly associated with less hours slept. This relationship was highly significant for less restoring sleep, fatigue, and drowsiness ( p<0.0005). No differences were found for age (p=0.294), primary tumor (p=0.225), level of information ( p=0.529), Karnofsky status (p=0.539), depression (p= 0.095), confusion (p=0.074), possible causes of awaking (p= 0.881), use of opioids (p= 0.798), use of hypnotics (p= 0.197), other morbidities ( p=0.460), or use of alcohol or coffee (p= 0.141). Patients admitted for pain control and/or those receiving opioids more frequently had drowsiness (p=0.01) Patients with lower Karnofsky scores had more drowsiness and diurnal hours slept (p=0.01). Anxiety created more difficulties in falling asleep, produced a less restoring sleep, and nightmares. Depression was associated with early awaking, nonrestorative sleep, fatigue, and nightmares. Confusion was associated with fatigue and nightmares. CONCLUSION: Sleep problems appear to be a significant issue for advanced cancerpatients. Attention to sleep disturbance needs to be incorporated into the routine practice in palliative care evaluation.
Authors: Susan L Beck; Anna L Schwartz; Gail Towsley; William Dudley; Andrea Barsevick Journal: J Pain Symptom Manage Date: 2004-02 Impact factor: 3.612
Authors: Karen O Anderson; Carl J Getto; Tito R Mendoza; Stephen N Palmer; Xin Shelley Wang; Cielito C Reyes-Gibby; Charles S Cleeland Journal: J Pain Symptom Manage Date: 2003-04 Impact factor: 3.612
Authors: R K Portenoy; H T Thaler; A B Kornblith; J M Lepore; H Friedlander-Klar; N Coyle; T Smart-Curley; N Kemeny; L Norton; W Hoskins Journal: Qual Life Res Date: 1994-06 Impact factor: 4.147
Authors: Barry V Fortner; Edward J Stepanski; Stephanie C Wang; Sarah Kasprowicz; H Heith Durrence Journal: J Pain Symptom Manage Date: 2002-11 Impact factor: 3.612
Authors: R K Portenoy; J Miransky; H T Thaler; J Hornung; C Bianchi; I Cibas-Kong; E Feldhamer; F Lewis; I Matamoros; M Z Sugar Journal: Cancer Date: 1992-09-15 Impact factor: 6.860
Authors: Cheryl Koopman; Bita Nouriani; Vanessa Erickson; Renu Anupindi; Lisa D Butler; Michael H Bachmann; Sandra E Sephton; David Spiegel Journal: Breast J Date: 2002 Nov-Dec Impact factor: 2.431
Authors: Jennifer L Steel; Lauren Terhorst; Kevin P Collins; David A Geller; Yoram Vodovotz; Juliana Kim; Andrew Krane; Michael Antoni; James W Marsh; Lora E Burke; Lisa H Butterfield; Frank J Penedo; Daniel J Buysse; Allan Tsung Journal: Psychosom Med Date: 2018-06 Impact factor: 4.312
Authors: Amy K Otto; Brian D Gonzalez; Richard E Heyman; Susan T Vadaparampil; Lee Ellington; Maija Reblin Journal: Psychooncology Date: 2019-11-12 Impact factor: 3.894
Authors: Carol M Baldwin; Marcia Grant; Christopher Wendel; Mark C Hornbrook; Lisa J Herrinton; Carmit McMullen; Robert S Krouse Journal: J Clin Sleep Med Date: 2009-08-15 Impact factor: 4.062
Authors: Martin Mueller; Stefanie Lohmann; Paul Thul; Arved Weimann; Eva Grill Journal: Health Qual Life Outcomes Date: 2010-04-16 Impact factor: 3.186
Authors: Sonia A Duffy; David L Ronis; Scott McLean; Karen E Fowler; Stephen B Gruber; Gregory T Wolf; Jeffrey E Terrell Journal: J Clin Oncol Date: 2009-03-16 Impact factor: 44.544